{"doi":"10.1158/2159-8290.cd-24-0231","title":"NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations","abstract":"Three generations of tyrosine kinase inhibitors (TKI) have been approved for anaplastic lymphoma kinase (ALK) fusion-positive non-small cell lung cancer. However, none address the combined need for broad resistance coverage, brain activity, and avoidance of clinically dose-limiting TRK inhibition. NVL-655 is a rationally designed TKI with >50-fold selectivity for ALK over 96% of the kinome tested. In vitro, NVL-655 inhibits diverse ALK fusions, activating alterations, and resistance mutations, showing ≥100-fold improved potency against ALKG1202R single and compound mutations over approved ALK TKIs. In vivo, it induces regression across 12 tumor models, including intracranial and patient-derived xenografts. NVL-655 inhibits ALK over TRK with 22-fold to >874-fold selectivity. These preclinical findings are supported by three case studies from an ongoing first-in-human phase I/II trial of NVL-655 which demonstrate preliminary proof-of-concept clinical activity in heavily pretreated patients with ALK fusion-positive non-small cell lung cancer, including in patients with brain metastases and single or compound ALK resistance mutations. Significance: By combining broad activity against single and compound ALK resistance mutations, brain penetrance, and selectivity, NVL-655 addresses key limitations of currently approved ALK inhibitors and has the potential to represent a distinct advancement as a fourth-generation inhibitor for patients with ALK-driven cancers.","journal":"Cancer Discovery","year":2024,"id":418571,"datarank":0.586803450814222,"base_score":3.912023005428146,"endowment":3.912023005428146,"self_citation_contribution":0.586803450814222,"citation_network_contribution":0.0,"self_endowment_contribution":0.586803450814222,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":49,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9506,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1206992,"name":"Joshua C. Horan","orcid":"0000-0003-4700-5215","position":1,"is_corresponding":false},{"id":1206993,"name":"Anupong Tangpeerachaikul","orcid":"0000-0002-6965-2678","position":2,"is_corresponding":false},{"id":1206994,"name":"Aurélie Swalduz","orcid":"0000-0002-8398-9373","position":3,"is_corresponding":false},{"id":1206995,"name":"Augusto Valdivia","orcid":"0000-0002-8039-0007","position":4,"is_corresponding":false},{"id":269859,"name":"Melissa L. Johnson","orcid":"0000-0001-9874-1314","position":5,"is_corresponding":false},{"id":616259,"name":"Benjamin Besse","orcid":"0000-0001-5090-8189","position":6,"is_corresponding":false},{"id":230277,"name":"D. Ross Camidge","orcid":"0000-0003-3430-3213","position":7,"is_corresponding":false},{"id":1206996,"name":"Toshio Fujino","orcid":"0000-0002-3640-3472","position":8,"is_corresponding":false},{"id":740188,"name":"Satoshi Yoda","orcid":"0000-0003-4201-1392","position":9,"is_corresponding":false},{"id":817270,"name":"Linh Nguyen-Phuong","orcid":"0000-0002-0175-9524","position":10,"is_corresponding":false},{"id":1206997,"name":"Hayato Mizuta","orcid":"0009-0006-3553-9091","position":11,"is_corresponding":false},{"id":1206998,"name":"Ludovic Bigot","orcid":"0009-0009-0820-5370","position":12,"is_corresponding":false},{"id":1207771,"name":"Catline Nobre","orcid":null,"position":13,"is_corresponding":false},{"id":53172,"name":"Jii Bum Lee","orcid":"0000-0001-5608-3157","position":14,"is_corresponding":false},{"id":1206999,"name":"Mi Ra Yu","orcid":"0000-0002-2141-0012","position":15,"is_corresponding":false},{"id":1207000,"name":"Scot Mente","orcid":"0000-0003-1355-4697","position":16,"is_corresponding":false},{"id":1129941,"name":"Yuting Sun","orcid":"0000-0002-0975-7902","position":17,"is_corresponding":false},{"id":1207001,"name":"Nancy E. Kohl","orcid":"0000-0003-4028-1866","position":18,"is_corresponding":false},{"id":1207002,"name":"James R. Porter","orcid":"0000-0002-6633-9475","position":19,"is_corresponding":false},{"id":1207003,"name":"Matthew D. Shair","orcid":"0000-0001-9764-212X","position":20,"is_corresponding":false},{"id":305410,"name":"Viola W. Zhu","orcid":"0000-0002-9313-3253","position":21,"is_corresponding":false},{"id":1544,"name":"Enriqueta Felip","orcid":"0000-0002-7620-0098","position":22,"is_corresponding":false},{"id":53174,"name":"Byoung Chul Cho","orcid":"0000-0002-5562-270X","position":23,"is_corresponding":false},{"id":845789,"name":"Luc Friboulet","orcid":"0000-0002-1129-4978","position":24,"is_corresponding":false},{"id":37113,"name":"Aaron N. Hata","orcid":"0000-0002-6127-318X","position":25,"is_corresponding":false},{"id":1207004,"name":"Henry E. Pelish","orcid":"0000-0003-2940-0326","position":26,"is_corresponding":false},{"id":230273,"name":"Alexander Drilon","orcid":"0000-0001-6806-9061","position":27,"is_corresponding":false},{"id":327190,"name":"W. Marston Linehan","orcid":"0000-0001-7373-3916","position":0,"is_corresponding":true}],"reference_count":82,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T01:57:09.067930Z","pmid":"39269178","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}